Page last updated: 2024-09-02

3-deoxyglucosone and epidermal growth factor

3-deoxyglucosone has been researched along with epidermal growth factor in 4 studies

Compound Research Comparison

Studies
(3-deoxyglucosone)
Trials
(3-deoxyglucosone)
Recent Studies (post-2010)
(3-deoxyglucosone)
Studies
(epidermal growth factor)
Trials
(epidermal growth factor)
Recent Studies (post-2010) (epidermal growth factor)
18687724,1552174,699

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (50.00)18.2507
2000's2 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Asahi, M; Fujii, J; Higashiyama, S; Kaneto, H; Kayanoki, Y; Suzuki, K; Takahashi, M; Taniguchi, N; Wenyi, C1
Asahi, M; Che, W; Higashiyama, S; Kaneto, H; Okado, A; Takahashi, M; Taniguchi, N1
Niwa, T; Tsukushi, S1
Akiyama, N; Hamada, Y; Hirooka, H; Horiuchi, S; Hotta, N; Kamiya, H; Li, W; Nakamura, J; Nakashima, E; Naruse, K; Oiso, Y; Takahashi, N1

Reviews

1 review(s) available for 3-deoxyglucosone and epidermal growth factor

ArticleYear
3-deoxyglucosone and AGEs in uremic complications: inactivation of glutathione peroxidase by 3-deoxyglucosone.
    Kidney international. Supplement, 2001, Volume: 78

    Topics: Amyloidosis; Animals; Apoptosis; Arteriosclerosis; Cell Division; Deoxyglucose; Epidermal Growth Factor; Erythrocytes; Glucose; Glutathione Peroxidase; Glutathione Reductase; Glycation End Products, Advanced; Heparin-binding EGF-like Growth Factor; Humans; Intercellular Signaling Peptides and Proteins; Oxidative Stress; Uremia

2001

Other Studies

3 other study(ies) available for 3-deoxyglucosone and epidermal growth factor

ArticleYear
Involvement of glycation and oxidative stress in diabetic macroangiopathy.
    Diabetes, 1996, Volume: 45 Suppl 3

    Topics: Animals; Aorta; Arteriosclerosis; Deoxyglucose; Diabetes Mellitus; Diabetic Angiopathies; DNA Damage; Epidermal Growth Factor; Gene Expression; Glycation End Products, Advanced; Heparin-binding EGF-like Growth Factor; Intercellular Signaling Peptides and Proteins; Muscle, Smooth, Vascular; Oxidation-Reduction; Oxidative Stress; Platelet-Derived Growth Factor; Rats; RNA, Messenger

1996
Selective induction of heparin-binding epidermal growth factor-like growth factor by methylglyoxal and 3-deoxyglucosone in rat aortic smooth muscle cells. The involvement of reactive oxygen species formation and a possible implication for atherogenesis in
    The Journal of biological chemistry, 1997, Jul-18, Volume: 272, Issue:29

    Topics: Acetylcysteine; Animals; Aorta, Thoracic; Arteriosclerosis; Cell Nucleus; Cells, Cultured; Cycloheximide; Dactinomycin; Deoxyglucose; Diabetic Angiopathies; Epidermal Growth Factor; Gene Expression; Guanidines; Heparin; Heparin-binding EGF-like Growth Factor; Intercellular Signaling Peptides and Proteins; Kinetics; Muscle, Smooth, Vascular; Peroxides; Pyruvaldehyde; Rats; Rats, Wistar; Reactive Oxygen Species; RNA, Messenger; Transcription, Genetic

1997
Suppression of 3-deoxyglucosone and heparin-binding epidermal growth factor-like growth factor mRNA expression by an aldose reductase inhibitor in rat vascular smooth muscle cells.
    Biochemical and biophysical research communications, 2004, Feb-06, Volume: 314, Issue:2

    Topics: Aldehyde Reductase; Animals; Blotting, Northern; Cells, Cultured; Deoxyglucose; Enzyme Inhibitors; Epidermal Growth Factor; Glucose; Glycation End Products, Advanced; Heparin-binding EGF-like Growth Factor; Imidazoles; Imidazolidines; Intercellular Signaling Peptides and Proteins; Mitogens; Muscle, Smooth, Vascular; Oxidative Stress; Rats; RNA, Messenger; Sorbitol; Thiobarbituric Acid Reactive Substances; Thymidine

2004